Drug Pipeline

36 drugs associated with Duchenne muscular dystrophy

DrugPhaseSponsor
Carvedilol

Carvedilol inhibits exercise induced tachycardia through its inhibition of beta adrenoceptors. Carvedilol's action on alpha-1 adrenergic receptors relaxes smooth muscle in vasculature, leading to reduced peripheral vascular resistance and an overall reduction in blood pressure. At higher doses, calcium channel blocking and antioxidant activity can also be seen. The antioxidant activity of carvedilol prevents oxidation of low density lipoprotein and its uptake into coronary circulation.

ApprovedSuzuka Hospital
12 mg/kg GSK2402968
Phase 1GlaxoSmithKline
3 mg/kg GSK2402968
Phase 1GlaxoSmithKline
6 mg/kg GSK2402968
Phase 1GlaxoSmithKline
9 mg/kg GSK2402968
Phase 1GlaxoSmithKline
delandistrogene moxeparvovec

Dystrophin exogenous gene

Phase 1Sarepta Therapeutics, Inc.
HG302
Phase 1HuidaGene Therapeutics Co., Ltd.
Prednisolone

The short term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation. Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days. Glucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kapp

Phase 1Kevin Flanigan
rAAVrh74.MCK.micro-Dystrophin
Phase 1Jerry R. Mendell
Spironolactone

Aldosterone is a key hormone in the renin-angiotensin-aldosterone system. By binding to the mineralocorticoid receptor at the distal tubules and collecting duct, it causes sodium reabsorption and potassium secretion, increases vascular stiffness and remodelling, and activates pro-inflammatory pathways. Spironolactone and its active metabolites are aldosterone antagonists that produce a potassium-sparing diuretic effect. They competitively bind to receptors at the aldosterone-dependent sodium-po

Phase 1Kevin Flanigan
Tadalafil 20 MG

Phosphodiesterase 5A inhibitor

Phase 1Cedars-Sinai Medical Center
Ataluren

Ataluren enables ribosomal readthrough of mRNA containing premature stop codons that otherwise would result in premature termination of protein chains. Use of ataluren allows cellular machinery to bypass nonsense mutations in genetic material, continue the translation process, and thereby restore the production of a full-length, functional protein. The research on the effects of Ataluren on the translation and stability of nonsense-containing mRNA in vitor show that Ataluren promoted readthroug

Phase 2PTC Therapeutics
CAP-1002
Phase 2Capricor Inc.
CRD007
Phase 2RSPR Pharma AB
DS-5141b
Phase 2Daiichi Sankyo Co., Ltd.
ENTR-601-45
Phase 2Entrada Therapeutics, Inc.
Eteplirsen

Eteplirsen is designed to bind to exon 51 of dystrophin pre-mRNA, resulting in exclusion of this exon during mRNA processing in patients with genetic mutations that are amenable to exon 51 skipping. Exon skipping is intended to allow for production of an internally truncated dystrophin protein, which was evaluated in Study 2 and Study 3 [ see Clinical Studies ( 14 ) ].

Phase 2Sarepta Therapeutics, Inc.
idebenone

Idebenone is a synthetic analogue of ubiquinone (also known as Coenzyme Q10), a vital cell antioxidant and essential component of the Electron Transport Chain (ETC). It has been proposed that by interacting with the ETC, idebenone increases ATP production required for mitochondrial function, reduces free radicals, inhibits lipid peroxidation, and consequently protects the lipid membrane and mitochondria from oxidative damage. More specifically, idebenone is thought to transfer electrons directly

Phase 2Santhera Pharmaceuticals
Myoblast transplantation

Somatic cell supplemental therapy

Phase 2CHU de Quebec-Universite Laval
NS-089/NCNP-02
Phase 2NS Pharma, Inc.
Load more